Skip to main navigation Skip to search Skip to main content

EMA and NICE appraisal processes for cancer drugs: current status and uncertainties

  • Rumona Dickson*
  • , Angela Boland
  • , Rui Duarte
  • , Eleanor Kotas
  • , Nerys Woolacott
  • , Robert Hodgson
  • , Rob Riemsma
  • , Sabine Grimm
  • , Bram Ramaekers
  • , Manuela Joore
  • , Nasuh Büyükkaramikli
  • , Eva Kaltenthaler
  • , Matt Stevenson
  • , Abdullah Pandor
  • , Steve Edwards
  • , Martin Hoyle
  • , Jonathan Shepherd
  • , Xavier Armoiry
  • , Miriam Brazzelli
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

39 Downloads (Pure)
Original languageEnglish
Pages (from-to)429-432
Number of pages4
JournalApplied Health Economics and Health Policy
Volume16
Issue number4
DOIs
Publication statusPublished - 1 Aug 2018
Externally publishedYes

Bibliographical note

Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Cite this